Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Axxellerance is a private German consulting and executive management services firm focused on the life sciences and related process industries. The company advises clients in biotechnology, pharmaceuticals, biologics, vaccines, chemicals, active ingredients, and pharmaceutical packaging, with services spanning strategy, operations, restructuring, transaction support, and interim executive leadership. Founded in January 2018 by Dr. Ralf Pfirmann, Axxellerance positions itself as a senior-level advisory partner for development and manufacturing businesses rather than as a drug developer. Its activities appear to center on accelerating strategy execution and operational excellence for highly regulated industrial and healthcare clients globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Axxellerance.